CD274 and Epstein-Barr virus infection: The patient responded well to chemotherapy with the R-CHOP chemotherapy combined with anti-CD20 antibody (Rituximab), which may to some extent suggest a potential association between EBV infection and FL, as well as the association between EBV infection and high PD-L1 expression.